Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deutsches Zentrum für Medizinal Cannabis (DZMC) is a specialized pharmaceutical wholesaler and service provider based in Germany, dedicated to the medical cannabis sector. The company focuses on the distribution of pharmaceutical-grade cannabis flowers and extracts to pharmacies, ensuring compliance with strict German narcotic and medicinal laws. Beyond logistics, DZMC provides extensive educational support and consulting services for physicians and pharmacists to improve patient access to cannabinoid-based therapies. By bridging the gap between producers and healthcare providers, the company plays a pivotal role in the German medical cannabis market. It operates as a subsidiary of Canify, leveraging a broad network to supply high-quality medicinal products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deutsches Zentrum für Medizinal Cannabis.